NEW YORK (GenomeWeb) – Diversigen announced today that the Crohn's & Colitis Foundation has selected the firm as a preferred provider for metagenomics and microbiome analysis services, as well as to serve as a central lab for generating and incorporating microbiome data into the foundation's IBD Plexus platform.

The IBD Plexus research information exchange platform centralizes data and biosamples from diverse research initiatives as part of the foundation's efforts to drive precision medicine and remodel IBD patient care.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.